Cytosorbents Aktie

0,8030 EUR -0,0350 EUR -4,18 %

17:18:50

FSE

0,9500 USD -0,0600 USD -5,94 %

25.07.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.50,38 Mio. EUR

Div. Rendite0,00%

WKNA12GDU

ISINUS23283X2062

SymbolCTSO

Cytosorbents Aktien News

Sortieren:Datum Meistgelesen

02.07.25PR NewswireCytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

24.06.25PR NewswireCytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

29.05.25PR NewswireCytoSorbents to Participate at the Jefferies Global Healthcare Conference

WerbungCytosorbents-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

22.05.25PR NewswireCytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

14.05.25PR NewswireCytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

01.05.25PR NewswireCytoSorbents Provides Regulatory Update for DrugSorb-ATR

29.04.25PR NewswireCytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

21.04.25PR NewswireCytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

17.04.25PR NewswireCytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

14.04.25PR NewswireCytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

31.03.25PR NewswireCytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

21.03.25PR NewswireCytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

30.07.24GlobeNewswireCytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

31.01.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO

23.01.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO

06.01.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO

29.12.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO

14.08.23PR NewswireCytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial

27.02.23PR NewswireCytoSorbents to Present at the Cowen 43rd Annual Health Care Conference

24.02.23PR NewswireCytoSorbents to Report Fiscal 2022 Operating and Financial Results

31.01.23PR NewswireCytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue

23.01.23PR NewswireCytoSorbents Announces Health Canada Regulatory Approval For Pivotal STAR-T Trial

17.01.23PR NewswireCytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs

29.12.22PR NewswireCytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement

21.12.22PR NewswireCytoSorbents Receives Recommendation from Independent Data and Safety Monitoring Board to Continue Pivotal STAR-T Trial As Planned Without Modifications

14.11.22PR NewswireCytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled

03.11.22PR NewswireCytoSorbents Reports Third Quarter 2022 Financial and Operational Results

02.11.22PR Newswire'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals

31.10.22PR NewswireNational Institutes of Health Grants Phase I SBIR Award to CytoSorbents to Test Novel Polymers for Cytokine and Endotoxin Removal from Septic Porcine Plasma

27.10.22PR NewswireCytoSorbents to Report Third Quarter 2022 Operating and Financial Results

12.10.22PR NewswireCytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

07.10.22PR NewswireCytoSorbents Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch

04.10.22PR NewswireCytoSorbents to Present at the Dawson James Securities 2022 Small Cap Growth Conference

27.09.22PR NewswireCytoSorbents Achieves ISO 13485 Certification of Princeton Manufacturing Facility in New Jersey

09.09.22PR NewswireThe U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma

07.09.22PR NewswireCytoSorbents to Present at the H.C. Wainwright 24th Annual Global Investment Conference

23.08.22PR NewswireTurkish Ministry of Health Grants National Reimbursement to CytoSorb®

17.08.22PR NewswireIsraeli Ministry of Health Approves National Coverage for CytoSorb®

02.08.22PR NewswireCytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms

02.08.22PR NewswireCytoSorbents Reports Second Quarter 2022 Financial and Operational Results

Cytosorbents News

Cytosorbents News: auf dieser Seite finden Sie alle Cytosorbents News und Nachrichten zur Cytosorbents Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Cytosorbents News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Cytosorbents News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.